iHuman IH Estimates

NYSE IH
$1.25 +0.02 (+1.63%)
At close: Sep 2, 2026 · 4:00 PM EDT
Analyst Estimates

iHuman Inc. Revenue Estimates

Periods 14
Next Period Q2 26
Consensus 23.90 M

Analysts expect iHuman Inc. to report revenue of 23.90 M for Q2 26, against a range of 22.73 M to 25.08 M. The most recent reported quarter, Q1 26, came in at 26.46 M, a 3.7% miss against the 27.48 M consensus.

Metric Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Reported (Actual) 38.61 M33.22 M34.44 M35.28 M32.53 M29.59 M28.99 M27.93 M28.90 M27.26 M26.46 M---
High Estimate --------29.55 M34.34 M29.21 M25.08 M26.38 M27.65 M
Low Estimate --------24.59 M28.29 M25.75 M22.73 M22.32 M23.23 M
Consensus Estimate --------27.07 M31.32 M27.48 M23.90 M24.35 M25.44 M
Analyst Estimates

iHuman Inc. Earnings Per Share (EPS) Estimates

Periods 14
Next Period Q2 26
Consensus 0.05

Analysts expect iHuman Inc. to report earnings per share of 0.05 for Q2 26, against a range of 0.05 to 0.05. The most recent reported quarter, Q1 26, came in at 0.00, a 91.4% miss against the 0.03 consensus.

Metric Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Reported (Actual) 0.140.110.100.090.060.060.070.080.010.010.00---
High Estimate --------0.080.070.030.050.040.03
Low Estimate --------0.060.050.030.050.040.03
Consensus Estimate --------0.070.060.030.050.040.03